100%(2)100% fanden dieses Dokument nützlich (2 Abstimmungen)
2K Ansichten2 Seiten
Salmeterol is a long-acting beta2-adrenergic agonist used to prevent and treat bronchospasm in asthma and chronic obstructive pulmonary disease. It works by acting as a bronchodilator and inhibiting inflammatory mediators in the lungs. Key contraindications include hypersensitivity, acute asthma exacerbation, and use with non-selective beta-blockers. Common side effects involve the cardiovascular, central nervous, and respiratory systems. It should be used cautiously in pregnancy and may interact with diuretics or monoamine oxidase inhibitors. Nurses monitor for signs of worsening asthma and ensure proper administration.
Originalbeschreibung:
Originaltitel
NAME of DRUG Generic Name : Salmeterol Xinafoate Classification: Beta2-Selective
Salmeterol is a long-acting beta2-adrenergic agonist used to prevent and treat bronchospasm in asthma and chronic obstructive pulmonary disease. It works by acting as a bronchodilator and inhibiting inflammatory mediators in the lungs. Key contraindications include hypersensitivity, acute asthma exacerbation, and use with non-selective beta-blockers. Common side effects involve the cardiovascular, central nervous, and respiratory systems. It should be used cautiously in pregnancy and may interact with diuretics or monoamine oxidase inhibitors. Nurses monitor for signs of worsening asthma and ensure proper administration.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
Salmeterol is a long-acting beta2-adrenergic agonist used to prevent and treat bronchospasm in asthma and chronic obstructive pulmonary disease. It works by acting as a bronchodilator and inhibiting inflammatory mediators in the lungs. Key contraindications include hypersensitivity, acute asthma exacerbation, and use with non-selective beta-blockers. Common side effects involve the cardiovascular, central nervous, and respiratory systems. It should be used cautiously in pregnancy and may interact with diuretics or monoamine oxidase inhibitors. Nurses monitor for signs of worsening asthma and ensure proper administration.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
NAME OF DRUG INDICATION CONTRAINDICATIONS SIDE EFFECTS
ACTION INTERACTION CONSIDERATIONS
Generic Name : Prevention of and - CNS: - Risk of severe - Assess allergy to
Long-acting agonist maintenance - Contraindicated with Headache, bronchospasm if salmeterol; Salmeterol that binds to beta2 therapy for hypersensitivity to tremor combined with pregnancy, acute xinafoate receptors in the lungs, bronchospasm in salmeterol, acute - CV: beta-blockers; asthma attack, causing select patients asthma attack, Tachycardia, use a worsening Classification: bronchodilation; with worsening or palpitations, cardioselective asthma, lactation also inhibits the asthma, chronic deteriorating hypertension beta-blocker and Beta2-selective release of obstructive asthma (life- - Respiratory: monitor patient - Ensure that drug adrenergic agonist inflammatory pulmonary threatening), acute Worsening of closely if this is not used to Antasthmatic mediators in the lung, disease, and airway obstruction. asthma, combination is treat acute blocking swelling and exercise-induced difficulty used asthma or with inflammation asthma - Use cautiously with breathing, - Potential for worsening or pregnancy, bronchospasm worsened deteriorating lactation. hypokalemia and asthma (risk of ECG death). abnormalities if - Instruct in the combined with proper use of diuretics; monitor diskus. patient very - Monitor use of closely inhaler; use of - Administer with more than 4 extreme caution puffs/day may to patients being worsen asthma; treated with obtain evaluation MAOIs or by physician. TCAs,or within 2 - Have patients wk of who experience discontinuation of exercise-induced such agents asthma use it 30– because the 60 min before action of activity. salmeterol may - Arrange for be potentiated by periodic these agents evaluation of respiratory condition.